Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

NCT02892422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lu AF35700

Sponsor

H. Lundbeck A/S